DHPLC can be used to detect low-level mutations in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 76-82

  Luquin, Natasha ^a,b   Yu, Bing ^a,b   Trent, Ronald J ^a,b   Pamphlett, Roger ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Amyotrophic lateral sclerosis; DHPLC; Mutation screening; SOD1; Somatic mutation

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DIDEOXYNUCLEOTIDE; DNA;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; HETERODUPLEX ANALYSIS; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUPEROXIDE DISMUTASE;

EID: 77649315943     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960802572699     Document Type: Article

References (19)

1. Schwarz S, Husstedt I, Bertram HP, Kuchelmeister K. Amyotrophic lateral sclerosis after accidental injection of mercury. J Neurol Neurosurg Psychiatry. 1996;60:698.
2. Andersen PM. Genetics of sporadic ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(Suppl 1):S37-41.
3. Siddique T. What is missing in ALS. Lancet Neurol. 2008;7:289-90.
4. Youssoufian H, Pyeritz RE. Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet. 2002;3:748-58.
5. Beck JA, Poulter M, Campbell TA, Uphill JB, Adamson G, Geddes JF, et al. Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum Mol Genet. 2004;13:1219-24.
6. Shaw PJ, Tomkins J, Slade JY, Usher P, Curtis A, Bushby K, et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neuron disease (MND). Neuroreport. 1997;8:3923-7.
7. Pamphlett R. Somatic mutation: a cause of sporadic neurodegenerative diseases? Med Hypotheses. 2004;62:679-82.
8. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389-92.
9. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615-22.
10. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, et al. Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J Mol Diagn. 2005;7:413-21.
11. Xiao W, Oefner PJ. Denaturing high-performance liquid chromatography: a review. Hum Mutat. 2001;17:439-74. (Pubitemid 32480082)
12. Yu B, Sawyer NA, Caramins M, Yuan ZG, Saunderson RB, Pamphlett R, et al. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neuron disease. J Clin Pathol. 2005;58:479-85.
13. Restagno G, Gomez A, Lombardo F, Cocco E, Calvo A, Ghiglione P, et al. The IVS1-319 ta of SOD1 gene is not an ALS-causing mutation. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:45-9.
14. Conforti FL, Sprovieri T, Mazzei R, Ungaro C, Tessitore A, Tedeschi G, et al. Sporadic ALS is not associated with VAPB gene mutations in southern Italy. J Negat Results Biomed. 2006;5:7.
15. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
16. Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain. 2000;123:2289-96.
17. Luquin N, Yu B, Trent RJ, Morahan JM, Pamphlett R. An analysis of the entire SOD1 gene in sporadic ALS. Neuromuscul Disord. 2008;18:545-52.
18. Krypuy M, Newnham GM, Thomas DM, Conron M, Dobrovic A. High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer. 2006;6:295.
19. Thomas RK, Nickerson E, Simons JF, Janne PA, Tengs T, Yuza Y, et al. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med. 2006;12:852-5.